YOU ARE DOWNLOADING DOCUMENT

Please tick the box to continue:

Transcript
Page 1: Report Stemi

DISCUSSION

ST ELEVATION MYOCARDIAL INFARCTION (STEMI)

Page 2: Report Stemi

DEFINITION

Acute coronary syndromes (ACS) is a term for situations where the blood supplied to the heart muscle is suddenly blocked.

• a group of conditions resulting from acute myocardial ischemia (insufficient blood flow to heart muscle)

• ranging from unstable angina (increasing, unpredictable chest pain) to myocardial infarction (heart attack).

Page 3: Report Stemi

INTRODUCTION

Page 4: Report Stemi

Histology

Page 5: Report Stemi
Page 6: Report Stemi

Pathophysiology

STEMI

Page 7: Report Stemi
Page 8: Report Stemi

PATHOPHYSIOLOGY

Page 9: Report Stemi

PATHOPHYSIOLOGY

Page 10: Report Stemi

PATHOPHYSIOLOGY

Page 11: Report Stemi

PATHOPHYSIOLOGY

Page 12: Report Stemi

PATHOPHYSIOLOGY

Page 13: Report Stemi
Page 14: Report Stemi

ACUTE CORONARY SYNDROME

Page 15: Report Stemi

DIAGNOSIS

Presenting symptoms

Electrocardiography

Serum markers

severe, persistent, typically chest pail; radiating to neck, jaw, or left shoulder and arm

Page 16: Report Stemi

CLINICALMANIFESTATION

Page 17: Report Stemi

Pathomechanism of Symptoms Angina Chest Pain

Acute Coron

ary Syndrome

Oxygen

supply

decrease ; Oxyg

en dema

nd increa

se

Ischemic of Heart

Metabolism aerob

to anaer

ob

Result ->

Lactate Acid increa

se

pH increase in

miocardium

Angina

Chest Pain

Page 18: Report Stemi
Page 19: Report Stemi

Electrocardiography

Page 20: Report Stemi

Electrocardiography

Page 21: Report Stemi

Because troponin and CK-MB levels do not become elevated in the serum until at least a few hours after the onset of MI symptoms and the diagnostic utility of these biomarkers is limited in that critical period. As a result, early decision making in patients with ACS often relies most heavily on the patient’s history and ECG findings.

Serum markers

Page 22: Report Stemi

DIAGNOSIS

Page 23: Report Stemi
Page 24: Report Stemi

GOAL OF TREATMENT

Relieve pain

Hemodynamic stabilization

Myocardial reperfusion

Prevent the complication

Page 25: Report Stemi

MANAGEMENT - Medications -

Page 26: Report Stemi
Page 27: Report Stemi

MANAGEMENT - Reperfusion Therapy -

Page 28: Report Stemi

MANAGEMENT - Reperfusion Therapy -

Page 29: Report Stemi

MANAGEMENT - Reperfusion Therapy -

Absolute contraindications• Any prior ICH• Known structural cerebral vascular lesion (e.g. arteriovenous

malformation)• Known malignant intracranial neoplasm (primary or metastatic)

Ischaemic stroke within 3 mo EXCEPT acute ischaemic stroke within 4.5 h

• Suspected aortic dissection• Active bleeding or bleeding diathesis (excluding menses)• Significant closed-head or facial trauma within 3 mo• Intracranial or intraspinal surgery within 2 mo• Severe uncontrolled hypertension (unresponsive to emergency

therapy)• For streptokinase, prior treatment within the previous 6 mo

Page 30: Report Stemi

MANAGEMENT - Reperfusion Therapy -

Relative contraindications• History of chronic, severe, poorly controlled hypertension• Significant hypertension on presentation (SBP >180 mmHg or DBP

>110 mmHg)• History of prior ischaemic stroke >3 mo• Dementia• Known intracranial pathology not covered in absolute

contraindications• Traumatic or prolonged (>10 min) CPR• Major surgery (<3 wk)• Recent (within 2 to 4 wk) internal bleeding• Non-compressible vascular punctures• Pregnancy• Active peptic ulcer• Oral anticoagulant therapy

Page 31: Report Stemi

COMPLICATIONS

Page 32: Report Stemi

PROGNOSIS

Page 33: Report Stemi

Related Documents